Efficacy of imatinib mesylate (STI571) in chronic neutrophilic leukemia with t(15;19): Case report
โ Scribed by In Keun Choi; Byung-Soo Kim; Kyung-A Lee; Sookwon Ryu; Hee Yun Seo; Hyeryoung Sul; Jong Gwon Choi; Hwa Jung Sung; Kyong Hwa Park; So Young Yoon; Sang Cheul Oh; Jae Hong Seo; Chul Won Choi; Sang Won Shin; Soo-Young Yoon; Yunjung Cho; Young-Kee Kim; Yeul Hong Kim; Jun Suk Kim
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 176 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Chronic neutrophilic leukemia (CNL) is a very rare myeloproliferative disorder. To determine the neoplastic origin of CNL, morphological and cytogenetical studies were made of colonies derived from hematopoietic progenitors of a patient with CNL. The patient's hematopoietic progenitors spontaneously
## BACKGROUND. T-cell lymphoid blastic phase (BP) transformation is rare in chronic myelogenous leukemia (CML). 2-amino-9-โค-D-arabinosyl-6-methoxy-9H-guanine (GW506U78), a prodrug of arabinosylguanine (ara-G), is effective in T-cell leukemias. ## METHODS. The authors present a case of a 48-year